4-[(3S)-3-[3-(3,5-dichlorophenyl)morpholin-4-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[(3S)-3-[4-(2,5-difluorophenyl)piperazin-1-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;molecular hydrogen;4-[(3S)-2-oxo-3-[4-[(1S)-1-phenylethyl]piperazin-1-yl]pyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide

C71H88Cl2F2N14O10S6 — CID 157213094

IUPAC4-[(3S)-3-[3-(3,5-dichlorophenyl)morpholin-4-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[(3S)-3-[4-(2,5-difluorophenyl)piperazin-1-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;molecular hydrogen;4-[(3S)-2-oxo-3-[4-[(1S)-1-phenylethyl]piperazin-1-yl]pyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide
SMILESC[C@@H](c1ccccc1)N1CCN([C@H]2CCN(c3ccc(S(=O)(=O)Nc4nccs4)cc3)C2=O)CC1.O=C1[C@@H](N2CCN(c3cc(F)ccc3F)CC2)CCN1c1ccc(S(=O)(=O)Nc2nccs2)cc1.O=C1[C@@H](N2CCOCC2c2cc(Cl)cc(Cl)c2)CCN1c1ccc(S(=O)(=O)Nc2nccs2)cc1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C25H29N5O3S2.C23H22Cl2N4O4S2.C23H23F2N5O3S2.7H2/c1-19(20-5-3-2-4-6-20)28-14-16-29(17-15-28)23-11-13-30(24(23)31)21-7-9-22(10-8-21)35(32,33)27-25-26-12-18-34-25;24-16-11-15(12-17(25)13-16)21-14-33-9-8-29(21)20-5-7-28(22(20)30)18-1-3-19(4-2-18)35(31,32)27-23-26-6-10-34-23;24-16-1-6-19(25)21(15-16)29-12-10-28(11-13-29)20-7-9-30(22(20)31)17-2-4-18(5-3-17)35(32,33)27-23-26-8-14-34-23;;;;;;;/h2-10,12,18-19,23H,11,13-17H2,1H3,(H,26,27);1-4,6,10-13,20-21H,5,7-9,14H2,(H,26,27);1-6,8,14-15,20H,7,9-13H2,(H,26,27);7*1H/t19-,23-;20-,21?;20-;;;;;;;/m000......./s1
InChIKeyASCNLBJGVBHQOV-RBKWEUQXSA-N
MW1598.88 g/mol
LogP12.73
Rot. Bonds19

About 4-[(3S)-3-[3-(3,5-dichlorophenyl)morpholin-4-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[(3S)-3-[4-(2,5-difluorophenyl)piperazin-1-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;molecular hydrogen;4-[(3S)-2-oxo-3-[4-[(1S)-1-phenylethyl]piperazin-1-yl]pyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide

4-[(3S)-3-[3-(3,5-dichlorophenyl)morpholin-4-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[(3S)-3-[4-(2,5-difluorophenyl)piperazin-1-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;molecular hydrogen;4-[(3S)-2-oxo-3-[4-[(1S)-1-phenylethyl]piperazin-1-yl]pyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide (PubChem CID 157213094) has the molecular formula C71H88Cl2F2N14O10S6 and a molecular weight of 1598.88 g/mol. Its IUPAC name is 4-[(3S)-3-[3-(3,5-dichlorophenyl)morpholin-4-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[(3S)-3-[4-(2,5-difluorophenyl)piperazin-1-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;molecular hydrogen;4-[(3S)-2-oxo-3-[4-[(1S)-1-phenylethyl]piperazin-1-yl]pyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide.

Molecular Properties

Compound Name4-[(3S)-3-[3-(3,5-dichlorophenyl)morpholin-4-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[(3S)-3-[4-(2,5-difluorophenyl)piperazin-1-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;molecular hydrogen;4-[(3S)-2-oxo-3-[4-[(1S)-1-phenylethyl]piperazin-1-yl]pyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide
PubChem CID157213094
Molecular FormulaC71H88Cl2F2N14O10S6
Molecular Weight1598.88 g/mol
Exact Mass1596.45
IUPAC Name4-[(3S)-3-[3-(3,5-dichlorophenyl)morpholin-4-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[(3S)-3-[4-(2,5-difluorophenyl)piperazin-1-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;molecular hydrogen;4-[(3S)-2-oxo-3-[4-[(1S)-1-phenylethyl]piperazin-1-yl]pyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide
SMILESC[C@@H](c1ccccc1)N1CCN([C@H]2CCN(c3ccc(S(=O)(=O)Nc4nccs4)cc3)C2=O)CC1.O=C1[C@@H](N2CCN(c3cc(F)ccc3F)CC2)CCN1c1ccc(S(=O)(=O)Nc2nccs2)cc1.O=C1[C@@H](N2CCOCC2c2cc(Cl)cc(Cl)c2)CCN1c1ccc(S(=O)(=O)Nc2nccs2)cc1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C25H29N5O3S2.C23H22Cl2N4O4S2.C23H23F2N5O3S2.7H2/c1-19(20-5-3-2-4-6-20)28-14-16-29(17-15-28)23-11-13-30(24(23)31)21-7-9-22(10-8-21)35(32,33)27-25-26-12-18-34-25;24-16-11-15(12-17(25)13-16)21-14-33-9-8-29(21)20-5-7-28(22(20)30)18-1-3-19(4-2-18)35(31,32)27-23-26-6-10-34-23;24-16-1-6-19(25)21(15-16)29-12-10-28(11-13-29)20-7-9-30(22(20)31)17-2-4-18(5-3-17)35(32,33)27-23-26-8-14-34-23;;;;;;;/h2-10,12,18-19,23H,11,13-17H2,1H3,(H,26,27);1-4,6,10-13,20-21H,5,7-9,14H2,(H,26,27);1-6,8,14-15,20H,7,9-13H2,(H,26,27);7*1H/t19-,23-;20-,21?;20-;;;;;;;/m000......./s1
InChIKeyASCNLBJGVBHQOV-RBKWEUQXSA-N
XLogP12.73
TPSA263.54 Ų
H-Bond Donors3
H-Bond Acceptors21
Rotatable Bonds19
Heavy Atoms105
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001598.88
LogP ≤ 512.73
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1021

Analyze 4-[(3S)-3-[3-(3,5-dichlorophenyl)morpholin-4-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[(3S)-3-[4-(2,5-difluorophenyl)piperazin-1-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;molecular hydrogen;4-[(3S)-2-oxo-3-[4-[(1S)-1-phenylethyl]piperazin-1-yl]pyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[(3S)-3-[3-(3,5-dichlorophenyl)morpholin-4-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[(3S)-3-[4-(2,5-difluorophenyl)piperazin-1-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;molecular hydrogen;4-[(3S)-2-oxo-3-[4-[(1S)-1-phenylethyl]piperazin-1-yl]pyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide?
The IUPAC name of 4-[(3S)-3-[3-(3,5-dichlorophenyl)morpholin-4-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[(3S)-3-[4-(2,5-difluorophenyl)piperazin-1-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;molecular hydrogen;4-[(3S)-2-oxo-3-[4-[(1S)-1-phenylethyl]piperazin-1-yl]pyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide (CID 157213094) is 4-[(3S)-3-[3-(3,5-dichlorophenyl)morpholin-4-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[(3S)-3-[4-(2,5-difluorophenyl)piperazin-1-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;molecular hydrogen;4-[(3S)-2-oxo-3-[4-[(1S)-1-phenylethyl]piperazin-1-yl]pyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide.
What is the SMILES notation for 4-[(3S)-3-[3-(3,5-dichlorophenyl)morpholin-4-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[(3S)-3-[4-(2,5-difluorophenyl)piperazin-1-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;molecular hydrogen;4-[(3S)-2-oxo-3-[4-[(1S)-1-phenylethyl]piperazin-1-yl]pyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide?
The canonical SMILES for 4-[(3S)-3-[3-(3,5-dichlorophenyl)morpholin-4-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[(3S)-3-[4-(2,5-difluorophenyl)piperazin-1-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;molecular hydrogen;4-[(3S)-2-oxo-3-[4-[(1S)-1-phenylethyl]piperazin-1-yl]pyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide is C[C@@H](c1ccccc1)N1CCN([C@H]2CCN(c3ccc(S(=O)(=O)Nc4nccs4)cc3)C2=O)CC1.O=C1[C@@H](N2CCN(c3cc(F)ccc3F)CC2)CCN1c1ccc(S(=O)(=O)Nc2nccs2)cc1.O=C1[C@@H](N2CCOCC2c2cc(Cl)cc(Cl)c2)CCN1c1ccc(S(=O)(=O)Nc2nccs2)cc1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].
What is the InChIKey of 4-[(3S)-3-[3-(3,5-dichlorophenyl)morpholin-4-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[(3S)-3-[4-(2,5-difluorophenyl)piperazin-1-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;molecular hydrogen;4-[(3S)-2-oxo-3-[4-[(1S)-1-phenylethyl]piperazin-1-yl]pyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide?
The InChIKey is ASCNLBJGVBHQOV-RBKWEUQXSA-N. The full InChI is InChI=1S/C25H29N5O3S2.C23H22Cl2N4O4S2.C23H23F2N5O3S2.7H2/c1-19(20-5-3-2-4-6-20)28-14-16-29(17-15-28)23-11-13-30(24(23)31)21-7-9-22(10-8-21)35(32,33)27-25-26-12-18-34-25;24-16-11-15(12-17(25)13-16)21-14-33-9-8-29(21)20-5-7-28(22(20)30)18-1-3-19(4-2-18)35(31,32)27-23-26-6-10-34-23;24-16-1-6-19(25)21(15-16)29-12-10-28(11-13-29)20-7-9-30(22(20)31)17-2-4-18(5-3-17)35(32,33)27-23-26-8-14-34-23;;;;;;;/h2-10,12,18-19,23H,11,13-17H2,1H3,(H,26,27);1-4,6,10-13,20-21H,5,7-9,14H2,(H,26,27);1-6,8,14-15,20H,7,9-13H2,(H,26,27);7*1H/t19-,23-;20-,21?;20-;;;;;;;/m000......./s1.
What are the key properties of 4-[(3S)-3-[3-(3,5-dichlorophenyl)morpholin-4-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[(3S)-3-[4-(2,5-difluorophenyl)piperazin-1-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;molecular hydrogen;4-[(3S)-2-oxo-3-[4-[(1S)-1-phenylethyl]piperazin-1-yl]pyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide?
4-[(3S)-3-[3-(3,5-dichlorophenyl)morpholin-4-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[(3S)-3-[4-(2,5-difluorophenyl)piperazin-1-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;molecular hydrogen;4-[(3S)-2-oxo-3-[4-[(1S)-1-phenylethyl]piperazin-1-yl]pyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide has a molecular weight of 1598.88 g/mol, XLogP of 12.73, 19 rotatable bonds, 3 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(3S)-3-[3-(3,5-dichlorophenyl)morpholin-4-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[(3S)-3-[4-(2,5-difluorophenyl)piperazin-1-yl]-2-oxopyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;molecular hydrogen;4-[(3S)-2-oxo-3-[4-[(1S)-1-phenylethyl]piperazin-1-yl]pyrrolidin-1-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide is sourced from PubChem (CID 157213094), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).